Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01698047 · ClinicalTrials.gov registry record · NA

Building Resiliency and Increasing Community Hope

A NA study of Depressive Symptoms, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
168
Enrollment target
3
Study locations

NCT01698047 is a NA study of Depressive Symptoms that has completed, run by University of California, Los Angeles. The registered enrollment target is 168 participants, below the 259-participant average among 60 other Depressive Symptoms trials with a reported enrollment target (35% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01698047, a NA study of Depressive Symptoms, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
168 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to build a scientific evidence base for the training and delivery of a depressive symptoms education program, developed by local community members, called a Resiliency Class (RC). The RC has strong elements of Cognitive Behavioral Therapy and is designed to be delivered as a psycho-educational class by non-professionals to improve mood. Depressive symptoms are common, especially in low-income, minority communities. Depressive symptoms that don't meet DSM-IV criteria for Major Depression still carry a significant amount of disability. Interventions that address sub-threshold depressive symptoms have been noted to result in a decreased likelihood of depression and diminished use of mental health services. Few interventions using a health education / health promotion focus are designed to be delivered by non-professionals to address individuals with mild to moderate depressive symptoms in low income, minority communities. This project will take place in the Centinela Valley, which roughly corresponds to Service Planning Area (SPA) 6 or South Los Angeles (SLA). This single-blind, randomized trial will utilize a wait-list control design where half of the participants enrolled in the study will be randomized to the Resiliency Class (7 sessions) and half will go to a wait-list control condition where they will receive 2 case management calls and referrals to social services. We propose to screen 1500 clients to detect about 450 participants with depressive symptoms (endorsed one item on the PHQ-2). We plan to enroll 400 participants, 200 in the resiliency class and 200 in the wait-list control condition. Primary outcomes measures will include depressive symptoms, function, and measures of resiliency. We will assess these measures at baseline and at 3 months after completion of the Resiliency Class or wait-list condition. After the completion of the first round of classes, we will conduct a preliminary analysis of the impact of the resiliency cl

Conditions Studied

Interventions

  • OTHER Case Management
  • BEHAVIORAL Resiliency Class

Study Locations (3)

California

  • Healthy African American Families - Los Angeles
  • 1st African Presbyterian Church - Los Angeles
  • Los Angeles Biomedical Research Institute - Torrance

Trial Details

FieldValue
Enrollment Target 168 participants
Start Date 2012-10
Est. Completion 2014-06
Phase NA

What the Registry Record Tells You About NCT01698047

The ClinicalTrials.gov registry entry for NCT01698047 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 259-participant average among 60 other Depressive Symptoms trials with a reported enrollment target (35% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Depressive Symptoms appearing as the primary indexed condition, and to 2 interventions - of which Case Management is the first listed.

NCT01698047 reports 3 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01698047 about?

NCT01698047 is a clinical study titled "Building Resiliency and Increasing Community Hope". The purpose of this study is to build a scientific evidence base for the training and delivery of a depressive symptoms education program, developed by local community members, called a Resiliency Class (RC). The RC has strong elements of Cognitive Behavioral Therapy and is designed to be delivered ...

What is the current status of trial NCT01698047?

This trial is currently completed. It is a NA study. The enrollment target is 168 participants. The study started on 2012-10. Estimated completion is 2014-06.

What conditions does trial NCT01698047 study?

This clinical trial studies the following conditions: Depressive Symptoms.

What interventions are being tested in trial NCT01698047?

The interventions under investigation include: Case Management (OTHER), Resiliency Class (BEHAVIORAL).

Who is sponsoring clinical trial NCT01698047?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01698047 being conducted?

This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depressive Symptoms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.